American Diabetes Association: Senate Should Send White House Strong Message of Support for Embryonic Stem Cell Research

Alexandria,
April 9, 2007

 The American Diabetes Association (ADA) – the nation’s leading voluntary health organization supporting diabetes research, information and advocacy – today urged the U.S. Senate to pass, with broad bipartisan support, the Stem Cell Research Enhancement Act (S.5). The ADA is a strong supporter of the legislation, which would accelerate stem cell research by easing existing restrictions and supporting research that uses embryonic stem cells, while maintaining strict ethical guidelines. Congress passed the legislation last year, but was unable to overcome President Bush’s veto. In January, the House of Representatives passed the legislation.


“The Senate this week has an opportunity to send a strong, clear message that this will be the year that the federal government lifts its damaging restrictions on stem cell research, which offers great potential for a cure for diabetes and other debilitating diseases,” said Darlene Cain, Chair of the American Diabetes Association. “Nearly 21 million American children and adults have waited too long for this research to progress. Now is the time to give researchers the full opportunity and resources to make advancements toward a cure.”


Federal regulations that President Bush announced in 2001 have restricted the number of human embryonic stem cell lines available for federally-funded research, and attempted usage of those lines has demonstrated that the number of adequate lines is even smaller due to contamination. Since 2001, scientists have discovered much better methods of deriving stem cell lines so that they do not face the same contamination issues. A significant expansion in the number of available lines is necessary in order to fully reap the medical rewards of stem cell research.


Stem cell research allows scientists to better explore how to control and direct stem cells so they can grow into other cells, such as insulin-producing beta cells found in the pancreas. Creating new beta cells could mean a cure for type 1 diabetes as they would serve as a replenishable source of cells for islet cell transplantation. They could also provide a powerful tool for controlling type 2 diabetes.


Diabetes is one of the nation’s most prevalent, debilitating and costly diseases. Nearly 21 million American children and adults have diabetes, up from 18 million when the Centers for Disease Control and Prevention last measured diabetes prevalence in 2003. If present trends continue, one in three Americans, and one in two minorities, born in 2000 will develop diabetes in their lifetime. The cost of diabetes in the U.S. in 2002 was at least $132 billion.

About the American Diabetes Association

More than 30 million Americans have diabetes, and every 21 seconds another person is diagnosed with diabetes. The American Diabetes Association (Association) is the global authority on diabetes and since 1940 has been committed to its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. To tackle this global public health crisis, the Association drives discovery in research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and provides support and advocacy for people living with diabetes, those at risk of developing diabetes and the health care professionals who serve them. For more information, please call the American Diabetes Association at 1-800-DIABETESS (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)